Amorsa Therapeutics Appoints Jeffrey Wiesen to Board of Directors
SOUTHBOROUGH, Mass., June 1, 2018 -- (Healthcare Sales & Marketing Network) -- Amorsa Therapeutics Inc., a neuropharmaceutical company pioneering the development of breakthrough treatments for nervous system disorders, is pleased to announce the appointme... Biopharmaceuticals, Neurology, Personnel Amorsa Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 1, 2018 Category: Pharmaceuticals Source Type: news

BD Names John DeFord Chief Technology Officer
FRANKLIN LAKES, N.J., June 1, 2018 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today appointed John A. DeFord as executive vice president and chief technology of... Diagnostics, Devices, Personnel BD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 1, 2018 Category: Pharmaceuticals Source Type: news

Lannett Receives FDA Approval For Levofloxacin Oral Solution; Imminent Launch Anticipated
PHILADELPHIA, June 1, 2018 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Levoflo... Biopharmaceuticals, Generics, FDA, Product Launch Lannett Company, Janssen Pharmaceuticals, Levofloxacin, Levaquin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 1, 2018 Category: Pharmaceuticals Source Type: news

Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
Jan-Eric Ahlfors, CEO of Fortuna Fix Inc., to present at IABS/CIRM 4th Cell Therapy Conference on June 6, 2018 in Los Angeles LONDON and MONTREAL, June 1, 2018 -- (Healthcare Sales & Marketing Network) -- Focusing on its Manufacturing, Fortuna Fix (&qu... Regenerative Medicine, Personnel Fortuna Fix, Spinal Cord Injury, Parkinson's Disease, Traumatic Brain Injury (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 1, 2018 Category: Pharmaceuticals Source Type: news

PENTAX Medical Announces U.S. Deal To Distribute Third Eye(R) Panoramic(TM) Imaging System For Colon Cancer Screening
Provides 'Panoramic' View to Detect Potentially Cancerous Polyps Standard Colonoscopes May Not See MONTVALE, N.J., May 31, 2018 -- (Healthcare Sales & Marketing Network) -- PENTAX Medical Company, a healthcare industry leader in diagnostic and therapeu... Devices, Gastroenterology, Oncology, Distribution PENTAX Medical, Avantis Medical Systems, Third Eye, colonoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news

TELA Bio(R) Announces Plans to Launch OviTex(R) Reinforced BioScaffolds in Europe
Distinct class of surgical implants for hernia procedures to launch in Europe MALVERN, Pa., May 31, 2018 -- (Healthcare Sales & Marketing Network) -- TELA Bio®, Inc., a surgical reconstruction company leading the development and commercialization o... Devices, Surgery, Product Launch TELA Bio, OviTex, Reinforced BioScaffold, hernia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news

Curis Announces FDA Fast Track Designation for Fimepinostat Development in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
LEXINGTON, Mass., May 31, 2018 -- (Healthcare Sales & Marketing Network) -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer, announced today that t... Biopharmaceuticals, Oncology, FDA Curis, fimepinostat, lymphoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news

Cingulate Therapeutics Strengthens Leadership with Two New Board Appointments
KANSAS CITY, Kan., May 31, 2018 -- (Healthcare Sales & Marketing Network) -- Cingulate Therapeutics LLC, a clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing its precision timed release drug delive... Biopharmaceuticals, Drug Delivery, Personnel Cingulate Therapeutics, Dexmethylphenidate, Dextroamphetamine, ADHD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news

Abbott Introduces the Afinion(TM) 2 Analyzer Rapid Test System for Diabetes Management
STATE-OF-THE-ART MULTI-ASSAY TEST SYSTEM HELPS PEOPLE WITH DIABETES GET THE HbA1c RESULTS THEY NEED WITHIN 3 MINUTES -- ALLOWING MORE TIME FOR CONSULTATION AND CARE DURING A SINGLE HEALTHCARE VISIT ABBOTT PARK, Ill., May 31, 2018 -- (Healthcare Sales & ... Diagnostics, Endocrinology, Product Launch Abbott, Afinion 2, HbA1c, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news

Alimera Sciences Announces the Reimbursement of ILUVIEN(R) in Spain
Spain becomes the seventh country in Europe to grant reimbursement for ILUVIEN ATLANTA, May 31, 2018 -- (Healthcare Sales & Marketing Network) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of pres... Biopharmaceuticals, Ophthalmology, Reimbursement Alimera Sciences, ILUVIEN, Diabetic Macular Edema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news

Encision Inc. Applauds the FDA's Safety Communication On The Dangers Of Monopolar Electrosurgery
Encision's AEM® Technology Is The Solution That Eliminates The Dangers BOULDER, Colo., May 31, 2018 -- (Healthcare Sales & Marketing Network) -- Encision Inc. (OTC:ECIA), a medical device company owning patented surgical technology that prevents da... Devices, Surgery, FDA Encision, electrosurgery, AEM Technology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news

Pivot Signs Option Agreement to Acquire Licensing Rights to Patented TriVair(TM) Nasal and Pulmonary Drug Delivery System For Its "RTIC" Ready-To-Infuse-Cannabis Powder
VANCOUVER, May 31, 2018 -- (Healthcare Sales & Marketing Network) - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that the Company has signed an Option Agreement wit... Devices, Drug Delivery, Licensing Pivot Pharmaceuticals, IP Med, Trivair Delivery System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2018 Category: Pharmaceuticals Source Type: news

Olympus Launches the DualKnife J, an ESD Electrosurgical Knife That Shortens Procedure Time
A New Evolution of the Best Selling ESD Knife Provides Lifting and Dissection in One Device CENTER VALLEY, Pa., May 30, 2018 -- (Healthcare Sales & Marketing Network) -- Olympus, a global technology leader in designing and delivering innovative solutio... Devices, Gastroenterology, Product Launch Olympus Medical Systems, DualKnife J, endoscopic submucosal dissection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news

Rani Therapeutics Appoints Dr. Rodolphe Ruffy as the Company's First Medical Director
SAN JOSE, Calif., May 30, 2018 -- (Healthcare Sales & Marketing Network) -- Rani Therapeutics, a pioneer in oral biologics, today announced that Rodolphe Ruffy, M.D. has joined the company as medical director. Dr. Ruffy brings decades of experience as a p... Biopharmaceuticals, Drug Delivery, Personnel Rani Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news

Legend Announces FDA Clearance of IND Application on CAR-T Immuno-cell Therapy for the Treatment of Multiple Myeloma
LCAR-B38M CAR-T therapy (JNJ-68284528) to be developed as part of strategic partnership between Legend and Janssen PISCATAWAY, N.J., May 30, 2018 -- (Healthcare Sales & Marketing Network) -- Legend Biotech, a subsidiary of GenScript Biotech Corporation... Biopharmaceuticals, Oncology, FDA Legend Biotech, GenScript Biotech, Janssen, CAR-T therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news

Propeller Health Raises $20 Million, Accelerating Development of Digital Medicines for Respiratory Health and Other Diseases
Financing led by Aptar Pharma, with participation from existing investors Safeguard Scientifics, Social Capital, Hikma, 3M Ventures and SR One MADISON, Wis., May 30, 2018 -- (Healthcare Sales & Marketing Network) -- Propeller Health, a leading digital ... Devices, Venture Capital Propeller Health, digital therapeutics, digital medicines (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news

FDA expedites review of Novartis drug Promacta(R) for first-line severe aplastic anemia (SAA)
Promacta receives FDA Priority Review for first-line treatment of SAA based on data showing 52% complete response rate and 85% overall response rate when added to standard immunosuppressive therapy (IST) Regulatory action underscores the treatment poten... Biopharmaceuticals, FDA Novartis, Promacta, eltrombopag, aplastic anemia, TPO receptor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news

FDA Broadens ClearGuard(R) HD Antimicrobial Barrier Cap Indications
ClearGuard HD Caps Have Been Shown to Reduce Central Line-Associated Bloodstream Infections in Hemodialysis Patients MAPLE GROVE, Minn., May 30, 2018 -- (Healthcare Sales & Marketing Network) -- Pursuit Vascular, Inc., manufacturer of ClearGuard HD Ant... Devices, FDA Pursuit Vascular, ClearGuard, Antimicrobial Barrier, hemodialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news

Circulating Tumor Cells To Help Stage Metastatic Breast Cancer, New Research To Be Featured at ASCO Annual Meeting
Study adds to significant body of evidence supporting clinical utility of CELLSEARCH BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., May 30, 2018 -- (Healthcare Sales & Marketing Network) -- Menarini Silicon Biosystems announced today that a new study has f... Diagnostics, Oncology Menarini Silicon Biosystems, circulating tumor cells, liquid biopsy, CELLSEARCH (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news

TrioxBio Announces Fast Track Designation Granted by U.S. FDA to Raviten(R) for the Treatment of Intradialytic Hypotension
Phase II clinical trials in patients undergoing hemodialysis to be initiated in Q4, 2018 NEWARK, Delaware, May 29, 2018 -- (Healthcare Sales & Marketing Network) -- TrioxBio Inc., a clinical-stage biopharmaceutical company specializing in the developme... Biopharmaceuticals, FDA TrioxBio, Raviten, ethylisothiouronium, Intradialytic Hypotension, hemodialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 29, 2018 Category: Pharmaceuticals Source Type: news

Zeto Announces First Dry Electrode, Wireless EEG Headset Approved by FDA for Clinical Use
Zeto EEG provides a better, more convenient experience to patients and technicians and faster turnaround time to hospitals than current technology SANTA CLARA, Calif., May 29, 2018 -- (Healthcare Sales & Marketing Network) -- Zeto, Inc., a privately he... Devices, Monitoring, Neurology, FDA Zeto, electroencephalography, EEG headset (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 29, 2018 Category: Pharmaceuticals Source Type: news

UCB Announces the Approval of CIMZIA(R) (certolizumab pegol) for Moderate-to-Severe Plaque Psoriasis, Representing an Important New Option for Patients in the U.S.
The U.S. Food and Drug Administration's (FDA) approval of CIMZIA® (certolizumab pegol) for use in moderate-to-severe plaque psoriasis marks the entry of UCB into immuno-dermatology CIMZIA Phase 3 psoriasis studies demonstrated significant and clinic... Biopharmaceuticals, Dermatology, FDA UCB , CIMZIA, certolizumab pegol, psoriasis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 29, 2018 Category: Pharmaceuticals Source Type: news

U.S. FDA Grants Priority Review to Astellas' New Drug Application for Gilteritinib for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
TOKYO, May 29, 2018 -- (Healthcare Sales & Marketing Network) -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D. "Astellas") announced today that the U.S. Food and Drug Administration (FDA) has accepted, with Priority R... Biopharmaceuticals, Oncology, FDA Astellas Pharma, gilteritinib, Acute Myeloid Leukemia, FLT3 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 29, 2018 Category: Pharmaceuticals Source Type: news

ADAPT Pharma(R) Launches NARCANDirect.com
New online platform for Group Purchasers of NARCAN® (naloxone HCl) Nasal Spray DUBLIN, May 29, 2018 -- (Healthcare Sales & Marketing Network) -- ADAPT Pharma® (Adapt) announced the launch of NARCANDirect.com, an easy-to-use online platform for ... Biopharmaceuticals, Product Launch ADAPT Pharma, NARCANDirect.com, NARCAN , naloxone (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 29, 2018 Category: Pharmaceuticals Source Type: news

Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
WAYNE, Pa., May 29, 2018 -- (Healthcare Sales & Marketing Network) -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for ... Biopharmaceuticals, Reimbursement Egalet Corp, SPRIX , ketorolac tromethamine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 29, 2018 Category: Pharmaceuticals Source Type: news

Lion TCR receives US$ 20 million to fund its personalized T cell therapy clinical trials against Liver cancer
SINGAPORE, May 28, 2018 -- (Healthcare Sales & Marketing Network) -- Lion TCR Pte Ltd, a clinical stage biotech pioneering T cell therapy against viral- related cancer, announced today they have raised US$ 20 million in its Series A financing round. The m... Biopharmaceuticals, Oncology, Venture Capital Lion TCR, LioCyx, T-cell, Hepatocellular carcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 28, 2018 Category: Pharmaceuticals Source Type: news

Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR
A Move Aimed at Enriching the Existing CNS Portfolio and Enhancing Strategic Synergy across International Markets HONG KONG, May 28, 2018 -- (Healthcare Sales & Marketing Network) -- Luye Pharma Group recently announced their acquisition of AstraZeneca... Biopharmaceuticals, Neurology, Acquisitions Luye Pharma, AstraZeneca, Seroquel, quetiapine, antipsychotic, antidepressant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 28, 2018 Category: Pharmaceuticals Source Type: news

Indivior Announces Regulatory Submission to Australia's Therapeutic Goods Administration (TGA) for SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection for the Treatment of Opioid Dependence
SLOUGH, England and RICHMOND, Va., May 25, 2018 -- (Healthcare Sales & Marketing Network) -- Indivior PLC (LON: INDV) today announced that it has filed a regulatory submission with Australia's Therapeutic Goods Administration (TGA) for SUBLOCADE™ (bupreno... Biopharmaceuticals, Drug Delivery, Regulatory Indivior, SUBLOCADE, buprenorphine, opioid use disorder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 25, 2018 Category: Pharmaceuticals Source Type: news

Neovasc Provides Highlights from EuroPCR; Symposium Generates Increased Interest in Reducer
VANCOUVER, May 25, 2018 -- (Healthcare Sales & Marketing Network) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, t... Devices, Interventional, Cardiology Neovasc, Tiara, Neovasc Reducer, angina pectoris, refractory angina (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 25, 2018 Category: Pharmaceuticals Source Type: news

IMBRUVICA(R) (ibrutinib) Plus GAZYVA(R) (obinutuzumab) Phase 3 iLLUMINATE Trial for First-Line Therapy of Chronic Lymphocytic Leukemia (CLL) Patients Met Primary Endpoint
Phase 3 iLLUMINATE trial met primary endpoint of progression-free survival (PFS) in patients with previously untreated CLL and Small Lymphocytic Lymphoma (SLL) compared to chlorambucil plus obinutuzumab as assessed by an Independent Review Committee (IRC) ... Biopharmaceuticals, Oncology AbbVie, IMBRUVICA, ibrutinib, GAZYVA, obinutuzumab, Chronic Lymphocytic Leukemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
AMSTERDAM, May 24, 2018 -- (Healthcare Sales & Marketing Network) -- BioGX B.V. continues its *BD MAX™ menu expansion with the launch of six additional CE-Mark infectious disease tests on Becton, Dickinson and Company's BD MAX™ Sample-to-Answer platform.... Diagnostics, Product Launch BioGX, BD , meningitis, vancomycin resistance (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

QT Vascular Enters Into Asset Purchase And Option Agreement With Teleflex
Teleflex will acquire the Company's commercial coronary products and an option to purchase the drug coated Chocolate Heart(TM) SINGAPORE, May 24, 2018 -- (Healthcare Sales & Marketing Network) -- QT Vascular Ltd., ("QT Vascular", and with its... Devices, Interventional, Cardiology, Acquisitions QT Vascular, Chocolate XD, Glider , Chocolate Heart, balloon catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

PiCSO therapy reduces infarct size in STEMI patients
Miracor Medical announces new publication at EuroPCR AWANS, Belgium, May 24, 2018 -- (Healthcare Sales & Marketing Network) -- Miracor Medical SA announced today the clinical results from the physician-sponsored OxAMI-PiCSO study were published in the ... Devices, Interventional, Cardiology Miracor Medical, OxAMI-PiCSO study, PiCSO Impulse System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development
Dr. David Tuck, CMO, to retire and return to academia LEXINGTON, Mass., May 24, 2018 -- (Healthcare Sales & Marketing Network) -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and eff... Biopharmaceuticals, Oncology, Personnel Curis , fimepinostat (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

Calidi Biotherapeutics, Inc. announces its corporate vision in groundbreaking cancer drug development and appoints Allan Camaisa as CEO
SAN DIEGO, May 24, 2018 -- (Healthcare Sales & Marketing Network) -- Calidi Biotherapeutics, Inc., formerly StemImmune, Inc., a clinical‐stage biotherapeutics company at the forefront of oncolytic virus-based immunotherapies for cancer, today announ... Biopharmaceuticals, Oncology, Personnel Calidi Biotherapeutics, StemImmune, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2018 Category: Pharmaceuticals Source Type: news

Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease
XIENCE Sierra™, the newest generation of XIENCE drug-eluting stents, received U.S. Food and Drug Administration (FDA) approval XIENCE stents are among the most-widely used and studied stents in the world and have an unparalleled safety record New fea... Devices, Interventional, Cardiology, FDA Abbott, XIENCE Sierra, drug eluting stent, coronary stent (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 23, 2018 Category: Pharmaceuticals Source Type: news

Access Scientific Completes Study Demonstrating Superior Anti-Thrombotic Properties of POWERWAND Midlines and Extended Dwell Catheters
SAN DIEGO, May 23, 2018 -- (Healthcare Sales & Marketing Network) -- Access Scientific, LLC announced completion of an in vivo study demonstrating the superior anti-thrombotic (i.e., anti-clotting) property of its unique intravascular catheter material, C... Devices Access Scientific, ChronoFlex, BioGUARD, POWERWAND, catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 23, 2018 Category: Pharmaceuticals Source Type: news